Mass Spec Roundup: Protein Landscapes and Adaptive Analysis
-
August 19, 2026
-
7 min
August 19, 2026
Emerging e-nose technology analyzes chemical signatures from breath and skin to support cancer diagnosis
August 3, 2026
August 1, 2026
The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.
August 10, 2026